Exelon Corp (EXC) stock
Close on Oct 30, 2026Market cap $47.65BP/E 16.8Yield 3.47%
Earnings
Exelon's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Exelon's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 11, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 30, 2026before the open | $7.32B | – | $0.70 | $0.87 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026before the open | $5.97B | +10.0% | $0.39 | $0.43 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026before the open | $7.24B | +7.9% | $0.90 | $0.91 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 12, 2026before the open | – | – | $0.58 | $0.59 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025before the open | – | – | $0.86 | $0.86 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025before the open | $5.43B | +1.2% | $0.39 | $0.39 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025before the open | $6.71B | +11.1% | $0.90 | $0.92 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 12, 2025before the open | $5.47B | +1.9% | $0.64 | $0.64 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024before the open | $6.15B | +2.9% | $0.70 | $0.71 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024before the open | $5.36B | +11.3% | $0.45 | $0.47 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024before the open | $6.04B | +8.6% | $0.66 | $0.68 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 21, 2024before the open | $5.37B | +15.0% | $0.62 | $0.60 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $5.98B | +23.4% | $0.70 | $0.67 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023before the open | $4.82B | +13.7% | $0.34 | $0.41 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023before the open | $5.56B | +4.4% | $0.67 | $0.70 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 14, 2023before the open | $4.67B | – | $0.43 | $0.43 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022before the open | $4.85B | -45.6% | $0.68 | $0.75 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 3, 2022before the open | $4.24B | – | $0.47 | $0.44 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 9, 2022before the open | $5.33B | – | $0.49 | $0.64 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021before the open | $8.91B | – | $1.23 | $1.09 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 5, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 24, 2021before the open | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Nov 3, 2020before the open | – | – | – | – | Release |
| Q2 FY2020ended Jun 30, 2020 | Aug 4, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Exelon's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted (non-GAAP) operating earningsnon-GAAP | FY2026 | $2.85 – $2.91 | – | New | Oct 30, 2026 |
| Adjusted (non-GAAP) operating earningsnon-GAAP | FY2026 | $2.81 – $2.91 | $2.81 – $2.91 | Reaffirmed | Jul 30, 2026 |
| adjusted (non-GAAP) operating EPS compounded annual growth targetnon-GAAP | FY2027 | +5% – +7% | +5% – +7% | Reaffirmed | Oct 30, 2024 |
| capital expenditures | FY2027 | $35.00B | – | New | Feb 21, 2024 |
| rate base growth | FY2027 | +7.5% | – | New | Feb 21, 2024 |
| operating EPS compounded annual growth | FY2028 | +5% – +7% | – | New | Jul 31, 2025 |
| operating EPS compounded annual growth | FY2028 | +5% – +7% | – | New | Feb 12, 2025 |
| rate base growth | FY2028 | +7.4% | – | Raised | Feb 12, 2025 |
Guidance vs results
The last range Exelon gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted (non-GAAP) operating earnings guidance | $2.64 – $2.74 | $2.76Σ4Q | Above range |
Guidance history
Every forecast Exelon put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 30, 2026 | operating EPS compounded annual growth | from 2025 to 2029 | +5% – +7% | – |
| Oct 30, 2026 | Adjusted (non-GAAP) operating earnings | FY2026 | $2.85 – $2.91 | New |
| Jul 30, 2026 | operating EPS compounded annual growth | 2025 to 2029 | +5% – +7% | – |
| Jul 30, 2026 | Adjusted (non-GAAP) operating earnings | FY2026 | $2.81 – $2.91 | Reaffirmed |
| May 6, 2026 | capital expenditures | over the next four years | $41.70B | – |
| May 6, 2026 | Adjusted (non-GAAP) operating earnings | FY2026 | $2.81 – $2.91 | Reaffirmed |
| May 6, 2026 | operating EPS compounded annual growth | from 2025 to 2029 | +5% – +7% | – |
| May 6, 2026 | rate base growth | over the next four years | +7.9% | – |
| Feb 12, 2026 | Adjusted (non-GAAP) operating earnings | FY2026 | $2.81 – $2.91 | New |
| Nov 4, 2025 | Adjusted (non-GAAP) operating earnings guidance | FY2025 | $2.64 – $2.74 | Reaffirmed |
| Nov 4, 2025 | operating EPS compounded annual growth | 2024 to 2028 | +5% – +7% | – |
| Jul 31, 2025 | operating EPS compounded annual growth | FY2028 | +5% – +7% | New |
| Jul 31, 2025 | Adjusted (non-GAAP) operating earnings guidance range | FY2025 | $2.64 – $2.74 | New |
| May 1, 2025 | operating EPS compounded annual growth | from 2024 to 2028 | +5% – +7% | – |
| May 1, 2025 | Adjusted (non-GAAP) operating earnings | FY2025 | $2.64 – $2.74 | Reaffirmed |
| Feb 12, 2025 | capital expenditures | the next four years | $38.00B | – |
| Feb 12, 2025 | Adjusted (non-GAAP) operating earnings | FY2025 | $2.64 – $2.74 | New |
| Feb 12, 2025 | operating EPS compounded annual growth | FY2028 | +5% – +7% | New |
| Feb 12, 2025 | rate base growth | FY2028 | +7.4% | Raised |
| Oct 30, 2024 | Adjusted (non-GAAP) operating earnings | FY2024 | $2.40 – $2.50 | Reaffirmed |
| Oct 30, 2024 | adjusted (non-GAAP) operating EPS compounded annual growth target | FY2027 | +5% – +7% | Reaffirmed |
| Aug 1, 2024 | Adjusted (non-GAAP) operating earnings guidance range | FY2024 | $2.40 – $2.50 | Reaffirmed |
| Aug 1, 2024 | fully regulated operating EPS compounded annual growth target | FY2027 | +5% – +7% | Reaffirmed |
| May 2, 2024 | Adjusted (non-GAAP) Operating Earnings | FY2024 | $2.40 – $2.50 | Reaffirmed |
| May 2, 2024 | fully regulated operating EPS compounded annual growth target | FY2027 | +5% – +7% | Reaffirmed |
| Feb 21, 2024 | capital expenditures | FY2027 | $35.00B | New |
| Feb 21, 2024 | Adjusted (non-GAAP) Operating Earnings | FY2024 | $2.40 – $2.50 | New |
| Feb 21, 2024 | operating EPS compounded annual growth | FY2027 | +5% – +7% | New |
| Feb 21, 2024 | rate base growth | FY2027 | +7.5% | New |
| Nov 2, 2023 | Adjusted (non-GAAP) Operating Earnings | FY2023 | $2.32 – $2.40 | Narrowed |
| Aug 2, 2023 | Adjusted (non-GAAP) Operating Earnings | FY2023 | $2.30 – $2.42 | Reaffirmed |
| May 3, 2023 | Adjusted (non-GAAP) Operating Earnings | FY2023 | $2.30 – $2.42 | Reaffirmed |
| Feb 14, 2023 | Adjusted (non-GAAP) Operating Earnings | FY2023 | $2.30 – $2.42 | New |
| Nov 3, 2022 | Adjusted (non-GAAP) Operating Earnings | FY2022 | $2.21 – $2.29 | Narrowed |
| Nov 3, 2022 | earnings per share growth | 2021-2025 | +6% – +8% | – |
| Aug 3, 2022 | Adjusted (non-GAAP) Operating Earnings | FY2022 | $2.18 – $2.32 | Reaffirmed |
| May 9, 2022 | Adjusted (non-GAAP) Operating Earnings | FY2022 | $2.18 – $2.32 | New |
| Nov 3, 2021 | Adjusted (non-GAAP) Operating Earnings | FY2021 | $2.70 – $2.90 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Exelon filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- News
- News
- Update
- Update
- Results